The rumors around the tech world and Wall Street are that IBM (NYSE: IBM) will cut as many as 15,000 jobs in the U.S. as part of a restructuring. The actual number is hard to pin down. IBM has been silent on the matter.
When IBM announced�lackluster earnings for the final�quarter of 2013, its management said the company would continue to “rebalance’ its workforce. This is apparently code for firing people. Analysts and the media have started to dig for what IBM will not disclose–how many workers and where?
CNET believes it has one piece of the puzzle:
The company wouldn’t comment on the number of people being laid off or what divisions would be most affected. However, one source familiar with the plans told CNET that the layoffs entailed up to 25 percent in the Systems and Technology group. This is the group that makes IBM servers and is often referred to as the “hardware” division.
The FT believes it has another:
Top 5 Medical Companies To Invest In Right Now: Insmed Inc.(INSM)
Insmed Incorporated, a biopharmaceutical company, focuses on the development of inhaled pharmaceuticals for the site-specific treatment of serious lung diseases. The company primarily focuses on the development of inhaled antibiotic therapy delivered via proprietary advanced pulmonary liposome technology in areas of high unmet need in lung diseases. Its lead product candidate includes ARIKACE, an inhaled antibiotic supported by positive phase 2 results for treating serious lung infections due to susceptible bacteria. The U.S. Food and Drug Administration has cleared the company's investigational new drug application to conduct a pivotal Phase 3 clinical trial of ARIKACE in nontuberculous mycobacteria lung infections. Insmed Incorporated was founded in 1999 and is based in Monmouth Junction, New Jersey.
Advisors' Opinion:- [By Garrett Cook]
Insmed (NASDAQ: INSM) shares shot up 40.31 percent to $17.49 after the company announced that the FDA granted Arikayce breakthrough therapy designation.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, biopharmaceutical company Insmed (NASDAQ: INSM ) has received a distressing two-star ranking.
Top Net Payout Yield Stocks To Buy For 2014: KBR Inc. (KBR)
KBR, Inc. operates as an engineering, construction, and services company supporting the energy, hydrocarbon, government services, minerals, civil infrastructure, power, and industrial sectors worldwide. Its Downstream business unit provides front end engineering design; detailed engineering; engineering, procurement, and construction (EPC); EPC management; and program management services to petrochemical, refining, coal gasification, and syngas markets. The company?s Government and Infrastructure business unit provides program and project management, contingency logistics, operations and maintenance, construction management, engineering, and other services to military and civilian branches of governments and private clients. Its Services business unit delivers engineering, construction, construction management, fabrication, maintenance, and turnaround services. It also offers maintenance, construction, and drilling support services for offshore oil and gas producing facili ties using semisubmersible vessels. This segment serves oil, gas, petrochemicals, and hydrocarbon processing industries, as well as power, alternate energy, pulp and paper, industrial and manufacturing, and pharmaceutical industries. The company?s Technology business unit offers various process technologies, including value-added technologies in the coal monetization, petrochemical, refining, and syngas markets. Its Upstream business unit constructs liquefied natural gas, gas-to-liquids, onshore oil and gas production facilities, offshore oil and gas production facilities, and onshore and offshore pipelines. The company?s Ventures business unit invests in and manages projects, where the company provides engineering, construction, construction management or operations, and maintenance services. KBR, Inc. was founded in 1901 and is based in Houston, Texas.
Advisors' Opinion:- [By Ben Levisohn]
Shares of Harsco have gained 4.7% to $26.43 today at 1:16 p.m., outpacing other construction & engineering companies. Dycom (DY) has advanced 0.5% to $30, KBR Inc. (KBR) has ticked up 0.1% to $33.03, Worthington Industries�(WOR) has risen 2.8% to $38.85�and Tutor Perini (TPC) has rallied 3.6% to $22.46.
- [By Monica Gerson]
KBR (NYSE: KBR) is projected to post its Q1 earnings at $0.38 per share on revenue of $1.77 billion.
Pier 1 Imports (NYSE: PIR) is expected to report its Q1 earnings at $0.20 per share on revenue of $422.81 million.
- [By Lisa Levin]
KBR (NYSE: KBR) shares fell 1.16% to touch a new 52-week low of $23.95 after UBS downgraded the stock from Buy to Neutral.
AEP Industries (NASDAQ: AEPI) shares touched a new 52-week low of $34.20. AEP shares have dropped 56.11% over the past 52 weeks, while the S&P 500 index has gained 15.91% in the same period.
- [By John Kell]
Among the companies with shares expected to actively trade in Friday’s session are Deckers Outdoor Corp.(DECK), KBR Inc.(KBR) and Pier 1 Imports Inc.(PIR)
Top Net Payout Yield Stocks To Buy For 2014: EXACT Sciences Corporation(EXAS)
Exact Sciences Corporation, a molecular diagnostics company, focuses on developing a molecular diagnostic technology for the early detection and prevention of colorectal pre-cancer and cancer. The company develops the Cologuard, a non-invasive stool-based DNA colorectal cancer screening test that is designed to detect each of the four stages of colorectal cancer, as well as pre-cancerous lesions. Its test includes proprietary and patented methods, which isolate and analyze the trace amounts of human DNA that are shed into stool every day from the exfoliation of cells that line the colon. The company?s Cologuard test is also used to detect blood in stool, utilizing an antibody-based fecal immunochemical test. It has a strategic alliance agreement with LabCorp under which it licenses its patents and patent applications relating to the stool-based colorectal cancer screening technology to LabCorp; a collaboration, license, and purchase agreement with Genzyme Corporation to d eliver intellectual property improvements through licenses; and a license agreement with MAYO Foundation for medical education and research. Exact Sciences Corporation was founded in 1995 and is headquartered in Madison, Wisconsin.
Advisors' Opinion:- [By John Udovich]
Biotech and the cancer treatment segment of the biotech market has been a hot area for some time with important cancer stocks like large cap Celgene Corporation (NASDAQ: CELG) and small caps�Array BioPharma (NASDAQ: ARRY), Cancer Genetics Inc (NASDAQ: CGIX), EXACT Sciences Corporation (NASDAQ: EXAS) and�MetaStat Inc (OTCMKTS: MTST) all producing a steady flow of important news�for investors this week or in recent weeks. Consider the following:
Top Net Payout Yield Stocks To Buy For 2014: MAKO Surgical Corp.(MAKO)
MAKO Surgical Corp., a medical device company, markets its advanced robotic arm solution and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specific osteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment. The company?s MAKOplasty partial knee arthroplasty solution enables resurfacing of one or two specific diseased compartments of the joint, preserving more soft tissue and healthy bone of the knee; and MAKOplasty Total Hip Arthroplasty, a surgical solution that enables orthopedic surgeons to pe rform total hip arthroplasty. In addition, it offers tactile guidance system, which allows orthopedic surgeons to treat degenerative knee osteoarthritis from early-stage unicompartmental degeneration through mid-stage multicompartmental degeneration with a modular knee implant system; and RESTORIS family of implants for use in single and bicompartmental knee resurfacing procedures. The company markets its products through direct sales force, as well as through independent orthopedic product agents and distributors. MAKO Surgical Corp. was founded in 2004 and is headquartered in Fort Lauderdale, Florida.
Advisors' Opinion:- [By Steve Symington]
Just a few weeks ago, I noted that�MAKO Surgical (NASDAQ: MAKO ) �had taken two steps to show the world just how serious it is about protecting its turf in robotically assisted orthopedic surgery.
- [By Steve Symington]
It's OK,�MAKO Surgical (NASDAQ: MAKO ) shareholders; you can exhale now.
Shares of the robotic surgery specialist traded up more than 4% after the company reported earnings yesterday. For those of you who are disappointed that the stock didn't absolutely skyrocket, remember that this muted response is a heck of a lot better than the violent 37% plunge investors endured after MAKO's dismal first quarter earnings last year.
- [By Bryan Murphy]
Investors looking for a turnaround story should put MAKO Surgical Corp. (NASDAQ:MAKO) on their watchlist, if not in their portfolio. And just to be clear, I specifically mean long-term investors, as opposed to short-term traders. MAKO has dropped some long-term hints that its long-term slump is about to be reversed and turned into a long-term rally.
Top Net Payout Yield Stocks To Buy For 2014: Helvetia Holding AG (HELN)
Helvetia Holding AG is a Switzerland-based holding company of the Helvetia Group, an internationally active, all-lines insurance service group. The Company divides its activities into country markets Switzerland, Germany, Italy, Spain and Other insurance units, which include Austria, France and the global reinsurance business, as well as the Corporate segment, which includes all the Helvetia Group activities, as well as financing companies and the Company. Helvetia Holding AG classifies its activities as life business, non-life business and other activities. The life business offers life insurance, pension plans and annuities, among others. The non-life business includes property, motor vehicle, liability and transport policies, as well as health and accidental insurance coverage. The reinsurance business, among others, is included in Other activities business. The Company operates through its branch offices and subsidiaries. Advisors' Opinion:- [By Tom Stoukas]
Helvetia Holding AG (HELN) added 3.3 percent to 412 Swiss francs. Switzerland�� fourth-biggest insurer said first-half profit rose because of increased life-insurance sales and an acquisition in France. Net income climbed to 179.5 million Swiss francs ($192 million) in the six months through June, beating the average analyst estimate of 164.4 million francs.
Top Net Payout Yield Stocks To Buy For 2014: JetBlue Airways Corporation(JBLU)
JetBlue Airways Corporation provides passenger air transportation services in the United States. As of December 31, 2011, it operated approximately 700 daily flights to 70 destinations in 22 states, Puerto Rico, and Mexico; and 12 countries in the Caribbean and Latin America through a fleet of 120 Airbus A320 aircraft and 49 EMBRAER 190 aircraft. The company, through its subsidiary, LiveTV, LLC, provides in-flight entertainment, voice communication, and data connectivity systems and services for commercial and general aviation aircraft, including live in-seat satellite television, digital satellite radio, wireless aircraft data link service, and cabin surveillance systems. JetBlue Airways Corporation was founded in 1998 and is based in Forest Hills, New York.
Advisors' Opinion:- [By Brian Stoffel]
According to the Journal, officials at Southwest (NYSE: LUV ) �and Virgin America monitor NPS results vigilantly. And executives from both JetBlue (NASDAQ: JBLU ) and Delta (NYSE: DAL ) �"are convinced NPS results correlate to company profits, since stronger loyalty means stronger ticket sales."�
No comments:
Post a Comment